- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-40346527/Placebo
Total 54660 results
-
Janssen Research & Development, LLCCompletedInsomnia DisordersBelgium, United States, Germany, Poland, Japan, France
-
Janssen Research & Development, LLCTerminatedRheumatoid ArthritisPoland, Ukraine, Taiwan, United States, Colombia, Mexico, Japan, Korea, Republic of, Russian Federation, Argentina, Chile, Thailand, Hungary, Romania, Czechia, Latvia
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Janssen Research & Development, LLCActive, not recruitingHepatitis D, ChronicFrance, Taiwan, Italy, Germany, Japan, Spain, Russian Federation, Turkey, United Kingdom, Australia, Sweden, United States, New Zealand, China, Brazil
-
Janssen Research & Development, LLCCompletedNeoplasmChina, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
Janssen Research & Development, LLCCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCCompletedLymphoma, T-Cell, CutaneousFrance, United Kingdom, Spain, Portugal, United States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCActive, not recruitingExtraintestinal Pathogenic Escherichia Coli PreventionUnited States, France, Belgium, Spain, Netherlands
-
Janssen Research & Development, LLCRecruitingCrohn's DiseaseUnited States, Denmark, Belgium, Taiwan, Italy, Korea, Republic of, Germany, United Kingdom, Israel, Malaysia, Poland, Japan, New Zealand, Netherlands, China, Canada, France, Spain, Norway, Singapore, Croatia, Brazil, Switzerland, Aus... and more
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Rabin Medical CenterJanssen, LPRecruitingCentral Nervous System LymphomaIsrael
-
ActelionTerminatedPulmonary Arterial HypertensionGermany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
-
Janssen Research & Development, LLCCompleted
-
Octimet Oncology N.V.Terminated
-
Janssen Vaccines & Prevention B.V.Completed
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
Royal Marsden NHS Foundation TrustJanssen, LPUnknownGastrooesophageal CancerUnited Kingdom
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCRecruitingProstatic NeoplasmsUnited States, France, Spain, Netherlands
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Janssen Research & Development, LLCNo longer available
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
ActelionRecruitingHypertension, PulmonaryKorea, Republic of, Taiwan, Poland, Bulgaria, Ukraine, Belgium, South Africa, Belarus, Russian Federation
-
Kang Stem Biotech Co., Ltd.Not yet recruiting
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCWithdrawn
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2Korea, Republic of, United States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHealthy | Pharmacokinetics
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Kang Stem Biotech Co., Ltd.RecruitingSafety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (smart(FURIN))Dermatitis, AtopicKorea, Republic of
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo... and more
-
Janssen Research & Development, LLCCompleted